Online Consultation For Immunotherapy Doctors in Turkey

Immunotherapy encompasses advanced oncology treatments, including immune checkpoint inhibitors, monoclonal antibodies, CAR-T cell therapy, and cancer vaccines. It requires an oncologist experienced in precision immuno-oncology and managing immunotherapy-related side effects.

Look for JCI-accredited cancer centers or university-affiliated hospitals with:

• Dedicated oncology and immunotherapy departments
• Advanced molecular diagnostics and tumor profiling
• Facilities for immune monitoring, targeted therapy, and critical care support

Yes. MediGence enables virtual consultations with top immunotherapy oncologists in Turkey.

To prepare:

• Upload biopsy reports, PET-CT/MRI scans, pathology and immunohistochemistry results
• Share your complete treatment history and current medication list
• View specialist profiles, patient reviews, and clinical outcomes
• Book appointments securely through MediGence’s video consultation platform.

Immunotherapy is often given in cycles (every 2–4 weeks) depending on cancer type and drug protocol.

Typical Stay for One Cycle:

• Pre-treatment blood tests, immune markers: 1–2 days
• Immunotherapy infusion: Outpatient (2–6 hours)
• Observation and follow-up: 2–3 days
• Total Stay (per visit): 5–7 days
• MediGence can coordinate ongoing virtual follow-up or multi-cycle treatment planning in Turkey.

Yes. Turkey offers advanced cancer immunotherapy at lower costs compared to the US or Europe.

Benefits:

• Oncologists trained in the latest immuno-oncology therapies
• FDA- and EMA-approved immunotherapeutic drugs are available
• Multilingual medical staff and patient navigators

MediGence Services:

• Fast-track appointments with expert oncologists
• Visa, airport pickup, and hotel/accommodation support
• International medical report coordination and second opinion access

Qualifications:

• MD + DM/PhD in Oncology or Internal Medicine
• Specialisation in Immuno-oncology or Medical Oncology

Certifications:

• Member of ESMO, ASCO, TSMO (Turkish Society of Medical Oncology)
• Trained in handling immune-related adverse events

Experience:

• Experience in administering checkpoint inhibitors, CAR-T, and targeted immunotherapies
• Management of advanced cancers: melanoma, lung, renal, lymphoma, etc.
• Research publications or trial involvement in immunotherapy protocols

Yes. MediGence facilitates second opinions for:

• Suitability of immunotherapy based on genetic/tumor profiling
• Options like combination therapy, clinical trials, or switching protocols
• Understanding of expected side effects, response rate, and cost comparison

• Confirm JCI accreditation of the hospital
• Check the oncologist’s global affiliations (ESMO, ASCO, TSMO)
• Review treatment volumes, immunotherapy expertise, and patient testimonials
• Ask about experience in specific cancer types and management of side effects

During the consultation:

• The oncologist will review diagnostic reports and staging
• Explain the immunotherapy protocol, expected cycles, and drug mechanism
• Discuss possible side effects and supportive care needed
• Share an estimated cost, stay duration, and treatment schedule
• Answer your questions on logistics, remote follow-up, and lifestyle precautions